Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 10/20 | 1.00 |
| ▸ | MAPT | P10636 | 9/20 | 1.00 |
| ▸ | BACE1 | P56817 | 5/20 | 1.00 |
| ▸ | MMP9 | P14780 | 4/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 3/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 2/20 | 1.00 |
| ▸ | AKR1B1 | P15121 | 2/20 | 1.00 |
| ▸ | MAOA | P21397 | 2/20 | 1.00 |
| ▸ | MAOB | P27338 | 2/20 | 1.00 |
| ▸ | HDAC3 | O15379 | 2/20 | 1.00 |
| ▸ | HDAC1 | Q13547 | 2/20 | 1.00 |
| ▸ | HDAC2 | Q92769 | 2/20 | 1.00 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 2/20 | 1.00 |
| ▸ | STAT3 | P40763 | 2/20 | 1.00 |
| ▸ | NFKB2 | Q00653 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Curcumin SCHEMBL29876635 | 1.00 | APP (1.00) | APPMAPTBACE1MMP9NFKB1 | |
| Curcumin SCHEMBL2804734 | 1.00 | APP (1.00) | APPMAPTBACE1MMP9NFKB1 | |
| Curcumin SCHEMBL17629819 | 1.00 | APP (1.00) | APPMAPTBACE1MMP9NFKB1 | |
| Curcumin SCHEMBL250984 | 1.00 | APP (1.00) | APPMAPTBACE1MMP9NFKB1 | |
| Curcumin SCHEMBL6901740 | 1.00 | APP (1.00) | APPMAPTBACE1MMP9NFKB1 | |
| Curcumin SCHEMBL29358937 | 1.00 | APP (1.00) | APPMAPTBACE1MMP9NFKB1 | |
| Curcumin SCHEMBL17629818 | 1.00 | APP (1.00) | APPMAPTBACE1MMP9NFKB1 | |
| Curcumin SCHEMBL8336603 | 1.00 | APP (1.00) | APPMAPTBACE1MMP9NFKB1 | |
| Curcumin SCHEMBL8440 | 1.00 | APP (1.00) | APPMAPTBACE1MMP9NFKB1 | |
| Curcumin SCHEMBL29355906 | 1.00 | APP (1.00) | APPMAPTBACE1MMP9NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724079-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | Stealth BioTherapeutics Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| CN-119685277-A | Curcumin/dihydrocurcumin reductase mutant and application thereof | 山东金城生物药业有限公司 | 2025-03-25 | — | — | CN | claimed |
| WO-2024254164-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | STEALTH BIOTHERAPEUTICS INC. (US) | 2024-12-12 | — | — | WO | claimed |
| CN-118453944-A | Preparation method of external antibacterial hemostatic compound | 安徽中医药大学第一附属医院(安徽省中医院) | 2024-08-09 | — | — | CN | claimed |
| CN-116254146-B | Water-based diamond cutting fluid and preparation method thereof | 长治市龙晨科技有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-117752558-B | Moisturizing anti-inflammatory magnetic lip balm and preparation process thereof | 广州亿彩生物科技有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-117752558-A | Moisturizing anti-inflammatory magnetic lip balm and preparation process thereof | 广州亿彩生物科技有限公司 | 2024-03-26 | — | — | CN | claimed |
| EP-4301469-A1 | TREATMENT FOR MALIGNANT PLEURAL EFFUSION IN HUMANS | Signpath Pharma, Inc. (US) | 2024-01-10 | — | — | EP | claimed |
| CN-114621514-B | Polyethylene composition, polyethylene plastic particles, packaging product and application | 湖北远大天天明制药有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-116963724-A | Treatment for human malignant pleural effusion | 萨恩帕斯药物有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-116710123-A | Cytokine release and inhibition of cytokine storm | 萨恩帕斯药物有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-116254146-A | Water-based diamond cutting fluid and preparation method thereof | 长治市龙晨科技有限公司 | 2023-06-13 | — | — | CN | claimed |
| EP-4188398-A1 | SUPPRESSION OF CYTOKINE RELEASE AND CYTOKINE STORM | Signpath Pharma, Inc. (US) | 2023-06-07 | — | — | EP | claimed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | claimed |
| WO-2022187351-A1 | TREATMENT FOR MALIGNANT PLEURAL EFFUSION IN HUMANS | SIGNPATH PHARMA, INC (US) | 2022-09-09 | — | — | WO | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| CN-114621514-A | Polyethylene composition, polyethylene plastic particles, packaging product and application | 湖北远大天天明制药有限公司 | 2022-06-14 | — | — | CN | claimed |
| CN-112004845-B | Resin composition, laminate, semiconductor wafer with resin composition layer, substrate, and semiconductor device | 三菱瓦斯化学株式会社 | 2022-05-31 | — | — | CN | claimed |
| WO-2022026170-A1 | SUPPRESSION OF CYTOKINE RELEASE AND CYTOKINE STORM | SIGNPATH PHARMA, INC. (US) | 2022-02-03 | — | — | WO | claimed |
| WO-2026098542-A1 | PHARMACEUTICAL FORMULATIONS OF CURCUMIN AND/OR RESVERATROL COMPOUNDS | CALIWAY BIOPHARMACEUTICALS CO., LTD. (CN) | 2026-05-15 | — | — | WO | disclosed |
| US-20260109720-A1 | Complexes and Compounds of Mercaptophenols and Curcumin for Therapeutic Applications | GHOSH, Supratim (IN) | 2026-04-23 | — | — | US | disclosed |
| EP-4724079-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | Stealth BioTherapeutics Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4719404-A2 | METHODS FOR ADDRESSING INJECTION SITE REACTIONS ASSOCIATED WITH THE ADMINISTRATION OF BEVEMIPRETIDE | Stealth BioTherapeutics Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-12589081-B2 | Curcumin compositions for osteoarthritis and joint wellness | OMNIACTIVE HEALTH TECHNOLOGIES LIMITED (IN) | 2026-03-31 | — | — | US | disclosed |
| CN-121249605-A | Curcumin/dihydrocurcumin reductase MaCurA, coding gene and application | 山东理工大学 | 2026-01-02 | — | — | CN | disclosed |
| US-20250283088-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING MACULAR DEGENERATION | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2025-09-11 | — | — | US | disclosed |
| EP-4577181-A1 | ORAL CARE COMPOSITIONS | Adyani Consulting Corp. (US) | 2025-07-02 | — | — | EP | disclosed |
| US-12344842-B2 | Compositions and methods for treating and preventing macular degeneration | GENZYME CORPORATION (US) | 2025-07-01 | — | — | US | disclosed |
| CN-119685277-B | Curcumin/dihydrocurcumin reductase mutant and application thereof | 山东金城生物药业有限公司 | 2025-06-27 | — | — | CN | disclosed |
| WO-2025133936-A1 | NOVEL TOPICAL CREAM COMPOSITIONS FOR DIABETIC FOOT TREATMENT AND PROCESS FOR PREPARATION THEREOF | STABICON LIFE SCIENCES PVT LTD (IN) | 2025-06-26 | — | — | WO | disclosed |
| WO-2025109630-A1 | A WATER-SOLUBLE MICELLAR FORMULATION COMPRISING CURCUMIN AND PIPERINE AND PREPARATION METHOD THEREOF | WAGHODE PARAG (IN) | 2025-05-30 | — | — | WO | disclosed |
| CN-120001297-A | Capsule | 宝洁公司 | 2025-05-16 | — | — | CN | disclosed |
| EP-4547262-A1 | COMBINATION HERBAL MEDICINES FOR THE TREATMENT OF INFLAMMATORY BOWEL DISORDERS | Evinature Ltd. (IL) | 2025-05-07 | — | — | EP | disclosed |
| CN-115185104-B | Contact lens products | 星欧光学股份有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-119868249-A | Transdermal delivery formulation | 阿尔伯特爱因斯坦医学院 | 2025-04-25 | — | — | CN | disclosed |
| EP-4533059-A1 | ADDRESSING INJECTION SITE REACTIONS ASSOCIATED WITH THE ADMINISTRATION OF ELAMIPRETIDE | Stealth BioTherapeutics Inc. (US) | 2025-04-09 | — | — | EP | disclosed |
| CN-119745849-A | Application of bisamide curcumin compounds in preparation of oxidative stress injury protection drugs | 温州医科大学附属眼视光医院 | 2025-04-04 | — | — | CN | disclosed |
| CN-119685277-A | Curcumin/dihydrocurcumin reductase mutant and application thereof | 山东金城生物药业有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-119685277-A | Curcumin/dihydrocurcumin reductase mutant and application thereof | 山东金城生物药业有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-113660926-B | capsule | 宝洁公司 | 2025-03-07 | — | — | CN | disclosed |
| US-20250064721-A1 | TRANSDERMAL DELIVERY FORMULATIONS | ALBERT EINSTEIN COLLEGE OF MEDICINE | 2025-02-27 | — | — | US | disclosed |
| EP-4507745-A1 | EMULSION FORMULATIONS OF POORLY WATER-SOLUBLE COMPOUNDS | Menning, Mark Michael (US) | 2025-02-19 | — | — | EP | disclosed |
| CN-119343155-A | Emulsion formulations of poorly water-soluble compounds | 马克·迈克尔·门宁格 | 2025-01-21 | — | — | CN | disclosed |
| CN-114007734-B | Method for preparing capsules | 宝洁公司 | 2025-01-17 | — | — | CN | disclosed |
| WO-2024261784-A1 | ORGANOMETALLIC COMPLEXES AND COMPOUNDS OF MERCAPTOPHENOLS AND CURCUMIN FOR THERAPEUTIC APPLICATIONS | GHOSH SUPRATIM (IN) | 2024-12-26 | — | — | WO | disclosed |
| CN-114740190-B | For detecting aflatoxin B1Preparation method and application of electrochemical immunosensor | 武汉轻工大学 | 2024-12-20 | — | — | CN | disclosed |
| CN-119139280-A | Application of curcumin in preparation of medicine for treating retinopathy of premature infants | 天津市眼科医院 | 2024-12-17 | — | — | CN | disclosed |
| WO-2024254164-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | STEALTH BIOTHERAPEUTICS INC. (US) | 2024-12-12 | — | — | WO | disclosed |
| US-20240398725-A1 | NANOPARTICLES FOR CANCER TREATMENT | IMMIX BIOPHARMA, INC. | 2024-12-05 | — | — | US | disclosed |
| WO-2024243490-A2 | METHODS FOR ADDRESSING INJECTION SITE REACTIONS ASSOCIATED WITH THE ADMINISTRATION OF BEVEMIPRETIDE | STEALTH BIOTHERAPEUTICS INC. (US) | 2024-11-28 | — | — | WO | disclosed |
| WO-2024236274-A1 | MATERIAL AND METHOD FOR FORMING A MATERIAL | CQ Studio Limited (GB) | 2024-11-21 | — | — | WO | disclosed |
| CN-115524923-B | Negative photosensitive resin composition, patterning method and application thereof | 深圳市容大感光科技股份有限公司 | 2024-11-19 | — | — | CN | disclosed |
| US-20240358639-A1 | NANOPARTICLES FOR CANCER TREATMENT | IMMIX BIOPHARMA, INC. | 2024-10-31 | — | — | US | disclosed |
| CN-118771969-A | Curcumin-berberine hydrochloride co-amorphous substance and preparation method and application thereof | 闽江学院 | 2024-10-15 | — | — | CN | disclosed |
| EP-4422614-A1 | COMPOSITIONS AND METHODS USING A COMBINATION OF NUTRIENTS TO SUPPORT COGNITION AND EMOTIONAL HEALTH IN A MAMMAL | Société des Produits Nestlé S.A. (CH) | 2024-09-04 | — | — | EP | disclosed |
| US-12059493-B2 | Transdermal delivery formulations | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2024-08-13 | — | — | US | disclosed |
| CN-118453944-A | Preparation method of external antibacterial hemostatic compound | 安徽中医药大学第一附属医院(安徽省中医院) | 2024-08-09 | — | — | CN | disclosed |
| EP-4408405-A1 | NANOPARTICLES FOR CANCER TREATMENT | Immix Biopharma, Inc. (US) | 2024-08-07 | — | — | EP | disclosed |
| EP-4408374-A1 | MECHANOCHEMICALLY PRE-TREATED, HEAVY-METAL-FREE ACTIVATED CARBON PARTICLES A, TOPICAL MEDICATIONS, MEDICINAL PRODUCTS AND COSMETICS, PRODUCTION METHOD, AND USES | Smart Material Printing B.V. (NL) | 2024-08-07 | — | — | EP | disclosed |
| CN-118388421-A | Curcumin derivative, preparation method and application | 延边大学 | 2024-07-26 | — | — | CN | disclosed |
| CN-114209060-B | Turmeric composition with high bioavailability and preparation method thereof | 汤臣倍健股份有限公司 | 2024-07-19 | — | — | CN | disclosed |
| CN-116254146-B | Water-based diamond cutting fluid and preparation method thereof | 长治市龙晨科技有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-114276224-B | Multistage continuous crystallization method for curcumin crystals | 晨光生物科技集团股份有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-117752558-B | Moisturizing anti-inflammatory magnetic lip balm and preparation process thereof | 广州亿彩生物科技有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-113754525-B | Method for improving bulk density and fluidity of curcumin crystals | 天津大学 | 2024-05-28 | — | — | CN | disclosed |
| CN-118055762-A | Compositions and methods for supporting cognitive and emotional health in mammals using a combination of nutrients | 雀巢产品有限公司 | 2024-05-17 | — | — | CN | disclosed |
| EP-4366701-A1 | NANOPARTICLES FOR CANCER TREATMENT | Immix Biopharma, Inc. (US) | 2024-05-15 | — | — | EP | disclosed |
| WO-2024095290-A1 | A MICROPLASTIC-DEGRADATION COMPOSITION | XAVIER ELSY (IN) | 2024-05-10 | — | — | WO | disclosed |
| CN-117838872-A | Preparation method of polydopamine modified curcumin liposome and oral preparation method for ulcerative colitis | 成都大学 | 2024-04-09 | — | — | CN | disclosed |
| WO-2024068099-A1 | PEGYLATED NANOSTRUCTURES FOR PHOTOACOUSTIC IMAGING AND PHOTOTHERMAL THERAPY OF TUMOR LESIONS | OSPEDALE SAN RAFFAELE S.R.L. (IT) | 2024-04-04 | — | — | WO | disclosed |
| CN-117752558-A | Moisturizing anti-inflammatory magnetic lip balm and preparation process thereof | 广州亿彩生物科技有限公司 | 2024-03-26 | — | — | CN | disclosed |
| WO-2024042191-A1 | ORAL CARE COMPOSITIONS | BLISSANDMORE GMBH (DE) | 2024-02-29 | — | — | WO | disclosed |
| CN-117562883-A | Therapeutic eutectic solvent containing curcumin and preparation method thereof | 广东药科大学 | 2024-02-20 | — | — | CN | disclosed |
| US-20240050362-A1 | TRANSDERMAL DELIVERY FORMULATIONS | ALBERT EINSTEIN COLLEGE OF MEDICINE | 2024-02-15 | — | — | US | disclosed |
| EP-4301469-A1 | TREATMENT FOR MALIGNANT PLEURAL EFFUSION IN HUMANS | Signpath Pharma, Inc. (US) | 2024-01-10 | — | — | EP | disclosed |
| WO-2024003904-A1 | COMBINATION HERBAL MEDICINES FOR THE TREATMENT OF INFLAMMATORY BOWEL DISORDERS | EVINATURE LTD. (IL) | 2024-01-04 | — | — | WO | disclosed |
| EP-4294418-A1 | NOVEL ARTHRITIS EMULGEL COMPOSITION AND ITS PREPARATION PROCESS | Lyrus Life Sciences Pvt. LTD. (IN) | 2023-12-27 | — | — | EP | disclosed |
| WO-2023230322-A1 | ADDRESSING INJECTION SITE REACTIONS ASSOCIATED WITH THE ADMINISTRATION OF ELAMIPRETIDE | STEALTH BIOTHERAPEUTICS INC. (US) | 2023-11-30 | — | — | WO | disclosed |
| WO-2023225578-A2 | IMMUNO-ABLATION TREATMENT FOR SOLID TUMORS | NORTHWESTERN UNIVERSITY (US) | 2023-11-23 | — | — | WO | disclosed |
| CN-114621514-B | Polyethylene composition, polyethylene plastic particles, packaging product and application | 湖北远大天天明制药有限公司 | 2023-11-17 | — | — | CN | disclosed |
| US-11813356-B2 | Dosing regimens for treatment of proliferative disorders | SIGNPATH PHARMA, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| EP-4267116-A1 | CELLULAR HEALTH NUTRITIONAL PRODUCT | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (US) | 2023-11-01 | — | — | EP | disclosed |
| CN-116963724-A | Treatment for human malignant pleural effusion | 萨恩帕斯药物有限公司 | 2023-10-27 | — | — | CN | disclosed |
| WO-2023201042-A1 | EMULSION FORMULATIONS OF POORLY WATER-SOLUBLE COMPOUNDS | MENNING MARK MICHAEL (US) | 2023-10-19 | — | — | WO | disclosed |
| EP-3829564-B1 | CURCUMIN AND HOMOTAURINE FOR USE IN PREVENTING OR TREATING COGNITIVE DECLINE FORMS | ALERE VITAM S R L (IT) | 2023-10-18 | — | — | EP | disclosed |
| CN-113845677-B | Emulsion film and preparation method thereof | 东北农业大学 | 2023-10-13 | — | — | CN | disclosed |
| EP-4247343-A1 | MICELLAR SYSTEM FOR TRANSPORTING ACTIVE INGREDIENTS | Mivital AG (CH) | 2023-09-27 | — | — | EP | disclosed |
| US-20230293423-A1 | ANTIOXIDANT COMPOSITIONS AND METHODS OF PROTECTING SKIN, HAIR AND NAILS AGAINST HIGH ENERGY BLUE-VIOLET LIGHT | PETKOSKA ANKA T (MK) | 2023-09-21 | — | — | US | disclosed |
| CN-116761594-A | Cell health nutrition product | 葛兰素史克消费保健（美国）控股有限责任公司 | 2023-09-15 | — | — | CN | disclosed |
| CN-116725941-A | Chitosan-gelatin-citric acid gel and preparation method and application thereof | 中北大学 | 2023-09-12 | — | — | CN | disclosed |
| CN-116710123-A | Cytokine release and inhibition of cytokine storm | 萨恩帕斯药物有限公司 | 2023-09-05 | — | — | CN | disclosed |
| CN-116554519-A | Preparation method of zein-sodium alginate composite film embedded with curcumin | 江苏大学 | 2023-08-08 | — | — | CN | disclosed |
| US-20230241006-A1 | CURCUMIN COMPOSITIONS FOR OSTEOARTHRITIS AND JOINT WELLNESS | OMNIACTIVE HEALTH TECHNOLOGIES LIMITED (IN) | 2023-08-03 | — | — | US | disclosed |
| US-20230190839-A1 | COMPOSITIONS AND COMBINATIONS FOR SUBJECTS SUFFERING FROM ENDOMETRIOSIS | GYNOV (FR) | 2023-06-22 | — | — | US | disclosed |
| CN-116254146-A | Water-based diamond cutting fluid and preparation method thereof | 长治市龙晨科技有限公司 | 2023-06-13 | — | — | CN | disclosed |
| EP-4188398-A1 | SUPPRESSION OF CYTOKINE RELEASE AND CYTOKINE STORM | Signpath Pharma, Inc. (US) | 2023-06-07 | — | — | EP | disclosed |
| EP-4185282-A1 | COMBINATION OF CARVACROL WITH GALLIC ACID AND/OR CURCUMIN | Les Laboratoires Brothier (FR) | 2023-05-31 | — | — | EP | disclosed |
| EP-4178557-A1 | COMBINATION ANTI-CANCER PRODUCTS AND METHODS | Ankh Life Sciences Limited (IE) | 2023-05-17 | — | — | EP | disclosed |
| EP-4178551-A1 | CURCUMINOID COMPOSITIONS WITH HIGH BIOAVAILABILITY | Pisak, Mehmet Nevzat (TR) | 2023-05-17 | — | — | EP | disclosed |
| CN-116075724-A | Processing and imaging tissue samples | 阿科亚生物科学股份有限公司 | 2023-05-05 | — | — | CN | disclosed |
| WO-2023073079-A1 | COMPOSITIONS AND METHODS USING A COMBINATION OF NUTRIENTS TO SUPPORT COGNITION AND EMOTIONAL HEALTH IN A MAMMAL | Société des Produits Nestlé S.A. (CH) | 2023-05-04 | — | — | WO | disclosed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | disclosed |
| WO-2023052393-A1 | MECHANOCHEMICALLY PRE-TREATED, HEAVY-METAL-FREE ACTIVATED CARBON PARTICLES A, TOPICAL MEDICATIONS, MEDICINAL PRODUCTS AND COSMETICS, PRODUCTION METHOD, AND USES | SMART MATERIAL PRINTING B.V. (NL) | 2023-04-06 | — | — | WO | disclosed |
| WO-2023049530-A1 | NANOPARTICLES FOR CANCER TREATMENT | IMMIX BIOPHARMA, INC. (US) | 2023-03-30 | — | — | WO | disclosed |
| US-11576853-B2 | Antioxidant compositions and methods of protecting skin, hair and nails against high energy blue-violet light | CSI: Create.Solve. Innovate. LLC (US) | 2023-02-14 | — | — | US | disclosed |
| CN-115697366-A | Compositions and combinations for subjects with endometriosis | GYNOV公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-107106519-B | Therapeutic agent for human | 安克生命科学公司 | 2023-01-24 | — | — | CN | disclosed |
| WO-2023283380-A1 | NANOPARTICLES FOR CANCER TREATMENT | IMMIX BIOPHARMA, INC. (US) | 2023-01-12 | — | — | WO | disclosed |
| CN-115569136-A | Therapeutic agent for human | 安克生命科学公司 | 2023-01-06 | — | — | CN | disclosed |
| CN-115524923-A | Negative photosensitive resin composition, and patterning method and application thereof | 深圳市容大感光科技股份有限公司 | 2022-12-27 | — | — | CN | disclosed |
| WO-2022261466-A1 | LIPID CRYSTALLINE COMPOSITIONS WITH ENHANCED STABILITY FOR TOPICAL DELIVERY OF ACTIVE AGENT COMBINATIONS | ANKH LIFE SCIENCES LIMITED (IE) | 2022-12-15 | — | — | WO | disclosed |
| US-20220387534-A1 | ANTIOXIDANT AND ANTIMICROBIAL COMPOSITIONS AND METHODS OF USING THEM TO PROTECT SKIN OR TREAT OR PREVENT INFECTIONS | PETKOSKA ANKA T (MK) | 2022-12-08 | — | — | US | disclosed |
| CN-115252815-A | Curcumin compound and preparation method thereof | 深圳大学 | 2022-11-01 | — | — | CN | disclosed |
| CN-113264817-B | Curcumin crystallization method and application thereof | 晨光生物科技集团股份有限公司 | 2022-10-21 | — | — | CN | disclosed |
| CN-112996874-B | Adhesive composition | 味之素株式会社 | 2022-10-21 | — | — | CN | disclosed |
| WO-2022011132-A9 | COMBINATION ANTI-CANCER PRODUCTS AND METHODS | ANKH LIFE SCIENCES LIMITED (IE) | 2022-10-20 | — | — | WO | disclosed |
| EP-4069266-A1 | CURCUMIN COMPOSITIONS FOR OSTEOARTHRITIS AND JOINT WELLNESS | Omniactive Health Technologies Limited (IN) | 2022-10-12 | — | — | EP | disclosed |
| CN-115151249-A | Composition and method containing apoaequorin and curcumin | 昆西生物科学有限公司 | 2022-10-04 | — | — | CN | disclosed |
| US-20220305042-A1 | Drug Delivery Composition Comprising a Self-Assembled Gelator | THE CITY UNIVERSITY OF NEW YORK, REPRESENTED BY THE RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 2022-09-29 | — | — | US | disclosed |
| US-11446259-B2 | Curcuminoid compositions and preparation methods | INOVOBIOLOGIC INC. (CA) | 2022-09-20 | — | — | US | disclosed |
| CN-115058273-A | Cutting oil for metal processing and preparation method thereof | 南通科星化工股份有限公司 | 2022-09-16 | — | — | CN | disclosed |
| WO-2022187351-A1 | TREATMENT FOR MALIGNANT PLEURAL EFFUSION IN HUMANS | SIGNPATH PHARMA, INC (US) | 2022-09-09 | — | — | WO | disclosed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | disclosed |
| WO-2022175856-A1 | NOVEL ARTHRITIS EMULGEL COMPOSITION AND ITS PREPARATION PROCESS | LYRUS LIFE SCIENCES PVT LTD (IN) | 2022-08-25 | — | — | WO | disclosed |
| CN-109689608-B | Novel curcuminoid derivatives and their use as anti-cancer agents | 台湾中国医药大学 | 2022-07-29 | — | — | CN | disclosed |
| US-11389412-B2 | Curcuminoid chlorophyllin (CHL) compositions and methods of preparation and use | INOVOBIOLOGIC INC. (CA) | 2022-07-19 | — | — | US | disclosed |
| CN-114740190-A | For detecting aflatoxin B1Preparation method and application of electrochemical immunosensor | 武汉轻工大学 | 2022-07-12 | — | — | CN | disclosed |
| WO-2022140253-A1 | CELLULAR HEALTH NUTRITIONAL PRODUCT | GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC (US) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022140561-A1 | INHIBITION OF COVID-19 VIRUS BY MULTIPLE-COMPONENT FORMULATIONS | ANKH LIFE SCIENCES LIMITED (IE) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022125124-A1 | METHOD OF TREATMENT OF ACTINIC KERATOSES | ANKH LIFE SCIENCES LIMITED (IE) | 2022-06-16 | — | — | WO | disclosed |
| CN-114621514-A | Polyethylene composition, polyethylene plastic particles, packaging product and application | 湖北远大天天明制药有限公司 | 2022-06-14 | — | — | CN | disclosed |
| CN-114601802-A | Curcumin mesoporous calcium silicate solid dispersion and preparation method thereof | 常州大学 | 2022-06-10 | — | — | CN | disclosed |
| CN-112004845-B | Resin composition, laminate, semiconductor wafer with resin composition layer, substrate, and semiconductor device | 三菱瓦斯化学株式会社 | 2022-05-31 | — | — | CN | disclosed |
| WO-2022106576-A1 | MICELLAR SYSTEM FOR TRANSPORTING ACTIVE INGREDIENTS | MIVITAL AG (CH) | 2022-05-27 | — | — | WO | disclosed |
| EP-3996729-A1 | COMPOSITION FOR THE TREATMENT OF EMOTIONAL DISORDERS | Mousset, Pierre-Yves (FR) | 2022-05-18 | — | — | EP | disclosed |
| CN-114469909-A | Application of curcumin in preparation of medicine for treating ARL8A and/or ARL8B protein high-expression tumor | 中国医学科学院药用植物研究所 | 2022-05-13 | — | — | CN | disclosed |
| WO-2022099193-A1 | TRANSDERMAL DELIVERY FORMULATIONS | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2022-05-12 | — | — | WO | disclosed |
| CN-114276224-A | Multistage continuous crystallization method of curcumin crystal | 晨光生物科技集团股份有限公司 | 2022-04-05 | — | — | CN | disclosed |
| CN-114246849-A | Curcumin-peptide conjugates and formulations thereof | 奥斯生化药剂公司 | 2022-03-29 | — | — | CN | disclosed |
| CN-114209060-A | Curcuma rhizome composition with high bioavailability and preparation method thereof | 汤臣倍健股份有限公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-114195762-A | Curcumin analogue and synthesis method thereof | 山东省农业科学院 | 2022-03-18 | — | — | CN | disclosed |
| WO-2022026170-A1 | SUPPRESSION OF CYTOKINE RELEASE AND CYTOKINE STORM | SIGNPATH PHARMA, INC. (US) | 2022-02-03 | — | — | WO | disclosed |
| CN-114007734-A | Method for preparing capsules | 宝洁公司 | 2022-02-01 | — | — | CN | disclosed |
| WO-2022018378-A1 | COMBINATION OF CARVACROL WITH GALLIC ACID AND/OR CURCUMIN | LES LABORATOIRES BROTHIER (FR) | 2022-01-27 | — | — | WO | disclosed |
| WO-2022018378-A1 | COMBINATION OF CARVACROL WITH GALLIC ACID AND/OR CURCUMIN | LES LABORATOIRES BROTHIER (FR) | 2022-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11446259-B2 | Curcuminoid compositions and preparation methods | SUCNR1, GRHPR, SRM | APP 1723/4885MAPT 2522/4885BACE1 4232/4885 |
| US-20260109720-A1 | Complexes and Compounds of Mercaptophenols and Curcumin for Therapeutic Applications | MIF, SLC39A3, SOD1 | APP 4034/4885MAPT 2806/4885BACE1 2642/4885 |
| US-20220305042-A1 | Drug Delivery Composition Comprising a Self-Assembled Gelator | ABCB1, APEH, SHMT1 | APP 884/4885MAPT 1958/4885BACE1 1745/4885 |
| US-12589081-B2 | Curcumin compositions for osteoarthritis and joint wellness | FABP2, SLC25A20, S100A10 | APP 1251/4885MAPT 1140/4885BACE1 3307/4885 |
| US-11389412-B2 | Curcuminoid chlorophyllin (CHL) compositions and methods of preparation and use | CHLSN, STOM, SRMS | APP 3306/4885MAPT 2743/4885BACE1 4129/4885 |
| US-20230190839-A1 | COMPOSITIONS AND COMBINATIONS FOR SUBJECTS SUFFERING FROM ENDOMETRIOSIS | SQSTM1, TSG101, SUCNR1 | APP 2267/4885MAPT 2338/4885BACE1 1045/4885 |
| US-20240398725-A1 | NANOPARTICLES FOR CANCER TREATMENT | MCL1, TP53, PLK1 | APP 4544/4885MAPT 2202/4885BACE1 4101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.